Unknown

Dataset Information

0

Long-term HIV and tuberculosis outcomes in patients hospitalised with severe cutaneous adverse reactions.


ABSTRACT:

Background

Treatment-limiting severe cutaneous adverse reactions (SCAR) occur more commonly amongst persons with HIV-associated tuberculosis (TB). The impact of SCAR on long-term HIV/TB outcomes is unknown.

Methods

Patients with TB and/or HIV admitted to Groote Schuur Hospital, Cape Town, South Africa with SCAR between 1/10/2018 and 30/09/2021 were eligible. Follow-up data was collected for 6- and 12-month outcomes: mortality, TB and antiretroviral therapy (ART) regimen changes, TB treatment completion, and CD4 count recovery.

Results

Forty-eight SCAR admissions included: 34, 11, and 3 HIV-associated TB, HIV-only and TB-only patients with 32, 13 and 3 cases of drug reaction with eosinophilia and systemic symptoms, Stevens-Johnson syndrome/toxic epidermal necrolysis and generalised bullous fixed-drug eruption respectively. Nine (19%), all HIV-positive (eight co-infected with TB), were deceased at 12-months, and 12(25%) were lost to follow-up. Amongst TB-SCAR patients, seven (21%) were discharged on all four first-line anti-TB drugs (FLTD), while 12(33%) had regimens with no FLTDs; 24/37(65%) completed TB treatment. Amongst HIV-SCAR patients, 10/31(32%) changed ART regimen. If retained in care (24/36), median (IQR) CD4 counts increased at 12-months post-SCAR (115(62-175) vs. 319(134-439) cells/uL).

Conclusion

SCAR admission amongst patients with HIV-associated TB results in substantial mortality, and considerable treatment complexity. However, if retained in care, TB regimens are successfully completed, and immune recovery is good despite SCAR.

SUBMITTER: Veenstra S 

PROVIDER: S-EPMC10196841 | biostudies-literature | 2023 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Long-term HIV and tuberculosis outcomes in patients hospitalised with severe cutaneous adverse reactions.

Veenstra S S   Porter M N MN   Thwala B N BN   Pillay N N   Panieri M A MA   van der Westhuizen J J   Phillips E J EJ   Meintjes G G   Dlamini S S   Lehloenya R J RJ   Peter J J  

Journal of clinical tuberculosis and other mycobacterial diseases 20230508


<h4>Background</h4>Treatment-limiting severe cutaneous adverse reactions (SCAR) occur more commonly amongst persons with HIV-associated tuberculosis (TB). The impact of SCAR on long-term HIV/TB outcomes is unknown.<h4>Methods</h4>Patients with TB and/or HIV admitted to Groote Schuur Hospital, Cape Town, South Africa with SCAR between 1/10/2018 and 30/09/2021 were eligible. Follow-up data was collected for 6- and 12-month outcomes: mortality, TB and antiretroviral therapy (ART) regimen changes, T  ...[more]

Similar Datasets

| S-EPMC7840880 | biostudies-literature
| S-EPMC9389100 | biostudies-literature
| S-EPMC6687717 | biostudies-literature
| S-EPMC9952832 | biostudies-literature
| S-EPMC9976545 | biostudies-literature
| S-EPMC6340804 | biostudies-literature
| S-EPMC6039997 | biostudies-other
2024-09-18 | GSE275871 | GEO
| S-EPMC6342723 | biostudies-literature
| S-EPMC4013087 | biostudies-literature